tranilast
英
美
网络 曲尼司特; 肉桂氨茴酸; 曲尼斯特; 利喘平; 利喘贝
双语例句
- Effect of Tranilast on Collagen ⅳ Synthesis in Human Renal Tubular Epithelial Cells Induced with Connective Tissue Growth Factor
曲尼司特对结缔组织生长因子刺激人肾小管上皮细胞胶原Ⅳ合成的影响 - Inhibitory effects and mechanisms of tranilast on pulmonary fibrosis in rats
曲尼司特抗大鼠肺纤维化的作用及机制 - Pharmacokinetics and Bioequivalence of Compound Tranilast Tablets
复方曲尼司特片人体药动学及生物等效性研究 - Objective To learn the curative effect of chronic urticaria treated with tranilast.
目的了解曲尼司特治疗慢性荨麻疹的临床疗效。 - Determination of Salbutamol Sulfate in Compound Tranilast Tablets by RP-HPLC
RP-HPLC法测定复方曲尼司特片中硫酸沙丁胺醇的含量 - Objective To evaluate the safety and efficacy of tranilast capsule in the treatment of atopic dermatitis.
目的评价曲尼司特胶囊治疗特应性皮炎的安全性和有效性。 - A simple and rapid method for the determination of tranilast in human plasma by RP HPLC is described.
报道了用反相高效液相色谱法测定人血浆中曲尼司特浓度。 - Objective: To evaluate the efficacy and safety of compound tranilast capsules in treatment of mild and moderate bronchial asthma.
目的：评价复方曲尼司特胶囊（舒尔泰）对轻、中度支气管哮喘的平喘效果和不良反应。 - The Efficacy of Ebastine Combined with Tranilast in treating Chronic Urticaria
依巴斯汀联合曲尼司特治疗慢性荨麻疹疗效观察 - Effect of tranilast on proliferation in rat aortic smooth muscle cell
曲尼司特对大鼠主动脉平滑肌细胞增殖的影响 - Conclusion Tranilast could inhibit TGF-β_2 expression in cultured human trabecular meshwork cells.
结论曲尼司特能明显抑制小梁细胞TGFβ2的表达。 - Tranilast, as an anti-allergic agent, can stabilize the epicyte of mast cells and basophils and inhibit the release of the hypersensitive mediator.
曲尼司特（tranilast）作为一种抗变态反应药，可以稳定肥大细胞和嗜碱粒细胞的细胞膜，抑制过敏性物质释放。 - Conclusion: Ebastine combined with tranilast is an effective and safe method in treating chronic urticaria.
结论：依巴斯汀联合曲尼斯特治疗慢性荨麻疹疗效好，安全可靠。 - Annular elastolytic giant cell granuloma in an infant: Improvement after treatment with oral tranilast and topical pimecrolimus
婴儿环状弹性组织溶解性巨细胞肉芽肿：口服利喘平和局部外用吡美莫司治疗后获改善 - Treatment of atopic dermatitis with tranilast capsule: A multicenter, randomized, double-blind, placebo-controlled trial
曲尼司特胶囊治疗特应性皮炎的多中心随机双盲对照研究 - Observation of Tranilast in Treating Keloid and Hypertrophic Scar
曲尼司特胶囊治疗瘢痕疙瘩、增生性瘢痕疗效观察 - Effect of tranilast on airway remodeling of experimental COPD rats MALNUTRITION COMPLICATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE
曲尼司特对实验性慢性阻塞性肺疾病气道重塑的干预慢性阻塞性肺病合并营养不良 - Conclusion: Compound tranilast capsules is a safe and effective antiasthma drug.
结论：复方曲尼司特胶囊是一种安全有效的平喘药。 - Conclusions: Tranilast can prevent left ventricular fibrosis and improve left ventricular function after myocardial infarction.
结论：曲尼司特可减轻AMI后左室心肌纤维化，改善左室功能。 - The effect of tranilast on the down-regulation of beta-adrenoceptors
曲尼司特对豚鼠肺组织β肾上腺素受体向下调节的影响 - Influence of tranilast on expression of BMP-7, TGF-β 1 in rats with chronic cyclosporin A nephrotoxicity
曲尼司特对环孢素A致慢性肾毒性大鼠骨形成蛋白、转化生长因子β1表达的影响 - Objective: To explore the clinical efficacy of Ebastine combined with Tranilast in treating chronic urticaria.
目的：观察依巴斯汀联合曲尼司特治疗慢性荨麻疹的疗效。 - Objective: To explore the effects of tranilast on production of TGF-β 1, bFGF and IL-6 in normal and keloid dermal fibroblasts.
目的：研究曲尼司特对正常皮肤和瘢痕疙瘩成纤维细胞转化生长因子-β1（TGF-β1）、碱性成纤维细胞生长因子（bFGF）和白介素-6（IL-6）表达的影响。 - Tranilast ( a new membrane stabilizing agent of mast cells) was used to treat 206 patients of bronchial asthma and 104 patients of allergic rhinitis.
国产曲尼司特（一种新的肥大细胞膜稳定剂）被用于治疗支气管哮喘206例和变应性鼻炎104例。 - Result: ( 1) keloid fibroblasts secreted more TGF-β 1 than normal fibroblasts, and tranilast could inhibit the expression.
结果提示：（1）瘢痕疙瘩成纤维细胞较正常皮肤分泌更多的TGF-β1，曲尼司特可以明显抑制它的表达。 - Tranilast could reduce the synthesis of procollagen ⅰ/ ⅲ mRNA in normal and keloid fibroblasts. The inhibition ability became more evident when the concentration was increased.
曲尼司特能抑制正常皮肤和瘢痕疙瘩成纤维细胞Ⅰ、Ⅲ型前胶原mRNA表达，且随着浓度增加这种作用越加明显。 - Tranilast had the similar effects on the morphology of normal and keloid fibroblasts.
曲尼司特对正常皮肤和瘢痕疙瘩Fb的形态学影响相似。 - In addition, Tranilast had the similar effects on normal fibroblasts.
曲尼司特对正常皮肤成纤维细胞的影响大致相似。 - Silicone gel sheeting containing methylprednisolone aceponate and tranilast reached physicochemical properties of Pharmacopeia. 2.
结果：1、醋丙甲泼尼松龙曲尼斯特硅胶膜物理性能达到药典规定。